| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/20/2008 | EP1889906A1 High-copy-number, high-expression vector having methionine aminopeptidase gene therein |
| 02/20/2008 | EP1889823A1 13c,15n,2h labeled proteins for nmr structure determinations and their preparation |
| 02/20/2008 | EP1888763A2 Mannitol induced promoter systems in bacterial host cells |
| 02/20/2008 | EP1888762A1 Isolated dipeptides with ace inhibitor effect |
| 02/20/2008 | EP1888761A2 Recombinant n-glycosylated proteins from procaryotic cells |
| 02/20/2008 | EP1888114A2 Anti- mcp-1 antibodies, compositions, methods and uses |
| 02/20/2008 | EP1888108A2 Silicibacter sp. strain useful for genetic transformation of marine algae and production of antibiotic agents |
| 02/20/2008 | EP1789441A4 Notch mutations leading to increased receptor signaling |
| 02/20/2008 | EP1163349B1 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 02/20/2008 | EP0975745B1 Extracellular expression of cellulose binding domains (cbd) using bacillus |
| 02/20/2008 | EP0918872B1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/20/2008 | EP0907746B1 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 02/20/2008 | EP0731806B2 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
| 02/20/2008 | EP0689551B1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 02/20/2008 | CN101128597A Use of an agent produced from a parasite for prevention and control of diseases |
| 02/20/2008 | CN101128596A Blood pressure lowering peptides from glycomacropeptide |
| 02/20/2008 | CN101128585A Recombinant production of serum albumin |
| 02/20/2008 | CN101128475A Delta15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast |
| 02/20/2008 | CN101126105A Method for preparing antihypertensive peptides by using rice separated protein |
| 02/20/2008 | CN101126104A Method for preparing natural active collagen by using acid-enzyme composite |
| 02/20/2008 | CN101126103A Method for preparing corn protein peptide with high F valve by microorganism zymotechnics |
| 02/20/2008 | CN101125873A Recombinational cloning using nucleic acids having recombination sites |
| 02/20/2008 | CN100370033C Fishscale collagen production process |
| 02/20/2008 | CN100369934C Monoclonal antibody against human 4-1BBL and its use |
| 02/20/2008 | CN100369932C Monoclonal antibody against human CD154 and its use |
| 02/20/2008 | CN100369931C Monoclonal antibody against human B7-1 molecule and its use |
| 02/20/2008 | CN100369928C Blood pressure lowering polypeptide of corn gluten powder, its separation method and application |
| 02/19/2008 | USRE40089 Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor |
| 02/19/2008 | USRE40070 Antibody purification |
| 02/19/2008 | US7332595 DNA sequences encoding peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
| 02/19/2008 | US7332590 Using serial analysis of gene expression to identify tumor marker gene transcription products in respiratory system tissues; diagnosing/prognosing lung cancer |
| 02/19/2008 | US7332584 Antibodies that specifically bind PMS2 |
| 02/19/2008 | US7332582 which binds to B lymphoblastoid cells and induces proliferation and activation of peripheral blood lymphocytes; anti-tumor effect when injected into a tumor-bearing subject |
| 02/19/2008 | US7332581 Polypeptide variants with altered effector function |
| 02/19/2008 | US7332579 Antiproliferative agents; anticancer agents |
| 02/19/2008 | US7332572 Using type II membrane glycoprotein (4F2hc) as tool in identifying modulator which inhibit transcription in tumor cells; gene expresion inhibition and antitumors agents |
| 02/19/2008 | US7332341 Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells |
| 02/19/2008 | US7332333 Host cells containing multiple integrating vectors |
| 02/19/2008 | US7332331 Comprises gene transfer nucleotide sequences capable of differential transcription and secretion in brevibacillus and escherichia; bioreactors |
| 02/19/2008 | US7332322 Venezuelan equine encephalitis virus replicons with adaptive mutations in the genome and uses thereof |
| 02/19/2008 | US7332319 Heterologous alpha amylase expression in Aspergillus |
| 02/19/2008 | US7332316 Plant cytokinin oxidase |
| 02/19/2008 | US7332311 Comprises nucleotide sequence coding wax lyases for use in cosmetics, detergents, plastics and lubricants |
| 02/19/2008 | US7332310 Mutant of homoserine dehydrogenase from Corynebacterium and DNA encoding thereof |
| 02/19/2008 | US7332304 Fermentation of genetic engineered microorganisms; gastrointestinal disorders, antiallergens, inflammatory bowel disorders, antiarthritic agents |
| 02/19/2008 | US7332303 Product quality enhancement in mammalian cell culture processes for protein production |
| 02/19/2008 | US7332301 Insulin-like growth factor binding protein |
| 02/19/2008 | US7332300 Plant sugar transport proteins |
| 02/19/2008 | US7332299 Vector comprising nucleotide sequences sequences coding mannosidase for use in transformation and expression in nonmammalian cells; bioreactors |
| 02/19/2008 | US7332293 Neutral amino acid transporter binding method |
| 02/19/2008 | US7332289 Method of purifying protein |
| 02/19/2008 | US7332279 Comprises nucleotide sequences coding galactosyltransferase for use in treatment or prevention of aberrant cell surface glycosylation associated with tumor progression |
| 02/19/2008 | US7332272 characterizing a profile of expression levels of distinct biological molecules for two distinct sample types that differ by some relevant parameter, to characterize the difference between the two types in terms of expression profile; goal of understanding how drugs exert both therapeutic and toxic effect |
| 02/19/2008 | US7332174 Mutant forms of cholera holotoxin as an adjuvant |
| 02/19/2008 | US7332171 DNA sequences, vectors, host cells; proteins may be involved in immune avoidance |
| 02/19/2008 | US7332163 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 02/19/2008 | CA2423294C Method for synthesising peptides, peptide mimetics and proteins |
| 02/19/2008 | CA2328423C Amino acid modified polypeptides |
| 02/19/2008 | CA2267668C Method for enhancing the efficiency of gene transfer with stem cell factor polypeptide |
| 02/19/2008 | CA2267655C Assay using marked microbial host cell strains |
| 02/19/2008 | CA2253287C A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium |
| 02/19/2008 | CA2209858C Il-2r-associated polypeptide and dna molecules coding therefor |
| 02/19/2008 | CA2188874C Thermostable xylanases |
| 02/19/2008 | CA2186592C Alkaline bacillus amylase |
| 02/19/2008 | CA2171699C Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell |
| 02/19/2008 | CA2121364C Vaccines for actinobacillus pleuropneumoniae |
| 02/19/2008 | CA1341567C Dna sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides |
| 02/15/2008 | CA2554500A1 West nile virus antigent and assay |
| 02/14/2008 | WO2008019371A1 Combination therapy |
| 02/14/2008 | WO2008019315A2 Improved pre-implantation genetic diagnosis test |
| 02/14/2008 | WO2008019183A2 Biopolymer and protein production using type iii secretion systems of gram negative bacteria |
| 02/14/2008 | WO2008018641A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 02/14/2008 | WO2008018562A1 Production of useful protein such as antibody having modified sugar chain in egg yolk of transgenic chicken |
| 02/14/2008 | WO2008018555A1 HBsAg PARTICLE HAVING LOW ANTIGENICITY AND METHOD FOR PRODUCTION THEREOF |
| 02/14/2008 | WO2008018472A1 Novel monoclonal antibody and use of the same |
| 02/14/2008 | WO2008017734A1 Polymyxin derivatives and uses thereof |
| 02/14/2008 | WO2007142954A3 Codon optimization method |
| 02/14/2008 | WO2007130543A3 Method for producing stable mammalian cell lines producing high levels of recombinant proteins |
| 02/14/2008 | WO2007079458A3 Protein hydrolysates and method of making |
| 02/14/2008 | WO2007076537A3 Methods and compositions related to mutant kunitz domain i of tfpi-2 |
| 02/14/2008 | US20080040822 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080039402 Peptides and Peptidomimetics Binding to Cd23 |
| 02/14/2008 | US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression |
| 02/14/2008 | US20080039397 Polynucleotide encoding a tropoelastin polypeptide; expression products and hybrid molecules of the derivatives and variants |
| 02/14/2008 | US20080039385 Neublastin Variants |
| 02/14/2008 | US20080039372 Human chorionic gonadotropin antagonists and methods to prevent ovarian hyperstimulation |
| 02/14/2008 | US20080038792 Polyunsaturated fatty acids (PUFA); FabA-like beta-hydroxy acyl-ACP dehydrase activity and enoyl ACP-reductase activity; recombinant plant/microbial cells |
| 02/14/2008 | US20080038791 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038790 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038778 yeast having thermotolerance; obtained by controlling proofreading function of DNA polymerase in a loss-of-function mutant of yeast such as a gene-disruptant of yeast; produces beta-glucan efficiently |
| 02/14/2008 | US20080038777 Synthetic dog/human chimeric C-C chemokine receptor 2B |
| 02/14/2008 | US20080038776 Method for Preparing a Macromolecule of Bacterial Origin, Macromolecule thus Obtained, and Use of the said Molecule in the Prevention and Treatment of Inflammatory Rheumatic Disease |
| 02/14/2008 | US20080038753 Pharmaceutical manufacturing methods |
| 02/14/2008 | US20080038748 Antibodies That Recognize Cutting Edge Within The Tgf-Beta Activation Controlling Region |
| 02/14/2008 | US20080038735 Tus DNA binding domains |
| 02/14/2008 | US20080038721 Sequence Capable Of Accelerating Gene Expression At Moderately Low Temperature |
| 02/14/2008 | US20080038378 Pufa polyketide synthase systems and uses thereof |
| 02/14/2008 | US20080038287 Method For Identification, Isolation and Production of Antigens to a Specific Pathogen |
| 02/14/2008 | US20080038286 Glycosylated polypeptides produced in yeast mutants and methods of use thereof |
| 02/14/2008 | US20080038273 Preventing CD28 binding to B7 by monovalent fragments antibody called CD28.3 of which exhibit sufficient affinity for the antigen so that they can be used, in vitro or in vivo, to block the CD28 receptor without activation of this receptor; autoimmune diseases; transplant rejection |